Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Recurrence of the Tumor”

5,478 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,478 results

Testing effectiveness (Phase 2)UnknownNCT05170594
What this trial is testing

Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

Who this might be right for
Ovarian Cancer
The Second Affiliated Hospital of Shandong First Medical University 60
Testing effectiveness (Phase 2)Study completedNCT00559156
What this trial is testing

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 46
Testing effectiveness (Phase 2)Study completedNCT00881751
What this trial is testing

Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Medical University of South Carolina 95
Testing effectiveness (Phase 2)Study completedNCT02279602
What this trial is testing

Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 7
Large-scale testing (Phase 3)Study completedNCT00233402
What this trial is testing

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

Who this might be right for
Bladder Cancer
Photocure 789
Not applicableStudy completedNCT01664169
What this trial is testing

Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 307
Not applicableUnknownNCT00354705
What this trial is testing

Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients

Who this might be right for
Colon Cancer
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00068653
What this trial is testing

Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT00050986
What this trial is testing

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT04597294
What this trial is testing

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Who this might be right for
Gastric Cancer
Jagiellonian University 600
Testing effectiveness (Phase 2)Ended earlyNCT00126659
What this trial is testing

Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06006169
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 186
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT00504023
What this trial is testing

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Who this might be right for
Vulvar Cancer
Memorial Sloan Kettering Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT00293462
What this trial is testing

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerMucositis OralRadiation Toxicity+1 more
Marilyn Dodd 91
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00003623
What this trial is testing

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Alliance for Clinical Trials in Oncology 21
Testing effectiveness (Phase 2)Looking for participantsNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 60
Not applicableStudy completedNCT00897988
What this trial is testing

DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 40
Load More Results